The tape is hollowing out, not dipping inside strength. Nifty closed at 23,767 — its fourth loss in five sessions, sitting below its 200-day average and nearly 10% off its 52-week high — and the internals behind that slide are getting worse, not stabilising. The regime has shifted to transition with a neutral-to-down near-term read, and the flow of stocks leaving Stage 2 is running more than two-to-one over those entering it. These setups cleared the screen, but the backdrop for follow-through is deteriorating.
Trajectory: the internals are eroding, not consolidating
The slow structural gauge — the share of stocks above their 200-day average — has slid from 43.8 on 21 July to 41.3 today, a meaningful five-day drift that confirms this is not a routine pause. The fast short-term gauge, stocks above their 20-day average, has collapsed harder: from 43.6 on the 21st to 31.8 today, with two consecutive sessions below 32. Advance-decline told the same story — decliners swamped advancers 1,651 to 560 on the 22nd, and even today's modest recovery to 1,081 advancers versus 1,123 decliners is unconvincing. Net new highs went negative for the first time on the 23rd and barely recovered to a net +12 today. The Stage-2 cohort has narrowed by 1.3 over five days and the weekly transition count — 27 stocks moving Stage 1 to 2 against 64 moving Stage 2 to 3 — is the clearest signal: distribution is outpacing accumulation at a rate that makes the word "consolidation" hard to justify.
Leadership: IT and Health Care hold, but the bench is thin
Information Technology was the only sector to close meaningfully in the green today at +0.6%, and it is also where the Stage-2 cohort is expanding fastest over the last 20 days, alongside Health Care — which carries the strongest three-month return at +13.6% and has more than half its constituents in Stage 2. Real Estate rounds out the Stage-2 expansion list and leads the one-month table at +6.6%. That is a narrow leadership bench on a day when most of the market fell. Among names that cleared the screen, RPG Life Sciences sits at the intersection of Health Care's structural strength and the pullback list — notable precisely because its sector is one of the few where the advancing cohort is still widening, not shrinking.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| RPG Life Sciences Ltd | Health Care | 9.4 | +1.2% |
| Kapston Services Ltd | Industrials | 9.4 | +0.1% |
| Muthoot Microfin Ltd | Financials | 9.4 | +3.6% |
| Sky Gold and Diamonds Ltd | Consumer Discretionary | 9.4 | +0.7% |
| Kabra Extrusion Technik Ltd | Industrials | 9.4 | +7.3% |
| Tirupati Forge Ltd | Consumer Discretionary | 9.2 | -5.0% |
| Bharat Seats Ltd | Consumer Discretionary | 9.0 | +1.3% |
| Filatex India Ltd | Consumer Discretionary | 9.0 | +2.5% |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Information Technology | +0.6% | +3.4% | -2.3% | 42 | 31% |
| Consumer Staples | +0.2% | +0.2% | -2.9% | 54 | 25% |
| Industrials | -0.1% | -3.0% | +6.4% | 69 | 36% |
| Energy | -0.1% | -0.9% | -2.6% | 57 | 29% |
| Utilities | -0.1% | -3.2% | -1.1% | 63 | 20% |
| Financials | -0.2% | -1.8% | -2.3% | 61 | 34% |
| Real Estate | -0.2% | +6.6% | +11.9% | 49 | 22% |
| Materials | -0.3% | -0.2% | +0.5% | 69 | 31% |
| Consumer Discretionary | -0.5% | +2.5% | +5.1% | 68 | 36% |
| Health Care | -0.7% | +2.1% | +13.6% | 73 | 52% |
| Communication Services | -1.1% | +1.7% | +7.9% | 65 | 18% |
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.